2-Chloro-N-(1-hydroxypropan-2-yl)acetamide

Catalog No.: 
ACOZYJ319
CAS No.: 
119907-19-6
Molecular Formula: 
C5H10ClNO2
Molecular Weight: 
151.59
2-Chloro-N-(1-hydroxypropan-2-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$137.00InquiryInquiry
1g95%$312.00InquiryInquiry
5g95%$895.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N-(1-hydroxypropan-2-yl)acetamide
IUPAC Name2-chloro-N-(1-hydroxypropan-2-yl)acetamide
MDL No.MFCD14588096
Molecular FormulaC5H10ClNO2
Molecular Weight151.59
SMILESCC(CO)NC(=O)CCl
InChI KeyCHFSJZZCPILTEV-UHFFFAOYSA-N
Synonym2-chloro-N-(1-hydroxypropan-2-yl)acetamide;Acetamide, 2-chloro-N-(2-hydroxy-1-methylethyl)-
CAS No.119907-19-6

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACOZYJ319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOZYJ319 route product structure diagram
    ACOZYJ319119907-19-6
Inquiry

2. ACOZYJ319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOZYJ319 route product structure diagram
    ACOZYJ319119907-19-6
Inquiry

3. ACOZYJ319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOZYJ319 route product structure diagram
    ACOZYJ319119907-19-6
Inquiry

Comments (0)